Public health implications of delayed diagnosis and treatment of optic neuritis in low-resource settings: a retrospective study of visual recovery outcomes
Authors:
Open Access
- 21 November 2025
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Ophthalmology
- Vol. 5, 1642288
Abstract
Background: Optic neuritis (ON) is a common cause of visual loss in adults. It is commonly related to or occurs in the scenario of a demyelinating disease. Although treatment leads to visual recovery, diagnosis and treatment need to occur quickly, especially in lower-resource countries, where systems expect delays in care. Purpose: The goal of this study was to examine health-system delays in ON diagnosis and treatment and their effects on visual recovery. Methods: This retrospective review involved 100 cases of ON seen in a tertiary referral hospital from 2016 to 2023. Diagnosis was made of clinical features with confirmation by neuro-ophthalmological evaluation. MRI and visual evoked potentials (VEPs) were obtained if they were within reach. Visual recovery was defined as improvement of ≥3 Snellen lines at 3 months. Patients were given intravenous methylprednisolone (1 g/day for 3–5 days) and a tapered course of oral prednisolone. Delayed treatment was defined as the start of corticosteroids > 14 days after symptom onset, which was established for patients who did not start steroids on initial presentation. Logistic regression and ROC analysis were used to determine predictors of complete recovery. Results: 58% of patients experienced delayed treatment and had lower rates of complete visual recovery (31.0% vs. 66.7%, p < 0.01). Delayed treatment (OR 0.45; 95% CI 0.21–0.89) and baseline poor BCVA independently predicted poor visual recovery. Conclusion: In low-resource settings, the short-term visual outcomes of ON are worse with a delay in management. Prompt initiation of corticosteroids and improved referral pathways may aid in maximizing the recovery rate.Keywords
This publication has 27 references indexed in Scilit:
- Prevalence of pediatric and adult optic neuritis in the United States from 2016 to 2023Eye, 2025
- Autonomous artificial intelligence increases screening and follow-up for diabetic retinopathy in youth: the ACCESS randomized control trialNature Communications, 2024
- Artificial intelligence for telemedicine diabetic retinopathy screening: a reviewAnnals of Medicine, 2023
- Re: Chauhan et al.: Five-year trends in pediatric vision screening and access in the United States (Ophthalmology. 2023;130:120–122)Ophthalmology, 2023
- Detection of Longitudinal Ganglion Cell/Inner Plexiform Layer Change: Comparison of Two Spectral-Domain Optical Coherence Tomography DevicesAmerican Journal of Ophthalmology, 2021
- Keeping an eye on eye care: monitoring progress towards effective coverageThe Lancet Global Health, 2021
- The Lancet Global Health Commission on Global Eye Health: vision beyond 2020The Lancet Global Health, 2021
- Intense pulsed light treatment and meibomian gland expression for moderate to advanced meibomian gland dysfunctionClinical and Experimental Optometry, 2018
- Optic neuritisThe Lancet Neurology, 2014
- Optic NeuritisNew England Journal of Medicine, 2006